Evidence map›Paper›PMID 29540536›Full record

ArticleBioscience reports2018

Flurbiprofen axetil attenuates cerebral ischemia/reperfusion injury by reducing inflammation in a rat model of transient global cerebral ischemia/reperfusion.

Huisheng Wu, Chaoliang Tang, Lydia Wai Tai, Weifeng Yao, Peipei Guo, Junmou Hong, Xin Yang, Xinyi Li, Zhao Jin, Jianjuan Ke and 1 more

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Investigation of the hemostatic mechanism ofAnnals of translational medicine · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Huisheng WuDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Chaoliang TangDepartment of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
Lydia Wai TaiDepartment of Anesthesiology, The University of Hong Kong, Hong Kong, SAR China.
Weifeng YaoDepartment of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Peipei GuoDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Junmou HongDepartment of Cardiac Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Xin YangDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xinyi LiDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhao JinDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jianjuan KeDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yanlin WangDepartment of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China wyl0342@sina.com.
Wuhan University · CNZhongnan Hospital of Wuhan University · CNThird Affiliated Hospital of Sun Yat-sen University · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke has been ranked as the second cause of death in patients worldwide. Inflammation which is activated during cerebral ischemia/reperfusion (I/R) is an important mechanism leading to brain injury. The present study aimed to investigate the effect of flurbiprofen axetil on cerebral I/R injury and the role of inflammation in this process. Rats were subjected to sham operation or global cerebral I/R with or without flurbiprofen axetil (5 or 10 mg/kg). Global cerebral ischemia was achieved by occlusion of bilateral common carotid arteries combined with hypotension for 20 min followed by reperfusion for 72 h. Then the neurological deficit score, hippocampal cell apoptosis, levels of aquaporin (AQP) 4, AQP9, intercellular cell adhesion molecule-1 (ICAM-1), nuclear factor-κB (NF-κB), tumor necrosis factor (TNF-α), interleukin-1 β (IL-1β), thromboxane B2 (TXB2), and 6-keto-PGI1α were assessed. After reperfusion, neurological deficit score was significantly increased accompanied by severe neuronal damage (exacerbated morphological deficit, increased terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL)-positive cells and cleaved caspase-3 protein expression in hippocampal CA1 region). Cerebral I/R injury also enhanced expressions of TNF-α, IL-1β, NF-κB, AQP4 and AQP9 as well as TXB2 and TXB2/6-keto-PGI1α. All these changes were reversed by pretreatment with flurbiprofen axetil. Flurbiprofen axetil protects the brain from cerebral I/R injury through reducing inflammation and brain edema.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalBrain IschemiaDisease Models, AnimalFlurbiprofenHippocampusInflammationMaleNeuroprotective AgentsRatsReperfusion InjuryAnti-Inflammatory Agents, Non-SteroidalFlurbiprofenflurbiprofen axetilNeuroprotective Agentsbrain edemacerebral ischemia reperfusion injuryFlurbiprofen axetilinflammationstroke

Identifiers

PMID29540536
PMCPMC6435563
OpenAlexW2790363677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.